hervcov
“Understand the pathogenic role of HERV-W envelope protein and develop novel prognostic markers and therapeutic targets for personalized treatment of COVID-19-associated syndromes”
PROJECT UPDATES
- THE 2025 CONSORTIUM MEETING (ATHENS):
This year, Greece will host the consortium’s annual gathering. The event will be held at the National and Kapodistrian University of Athens, featuring two full days of presentations, discussions, and networking among project partners.
September 10 will be dedicated to internal meetings, during which partners will present the scientific progress achieved over the past year;
September 11 will focus on public engagement, offering an opportunity to present results to non-specialist audiences and raise awareness about Long COVID and ongoing research efforts. - NEW PUBBLICATIONS AVAILABLE: The Publications page is continuously updated with newly released scientific papers, reports and dissemination materials developed within the HERVCOV project. Check the section regularly to stay informed about the consortium’s most recent research achievements.
- 100th EGPRN MEETING, 8-11 May 2025, Partners from the HERVCOV consortium took part in the 100th European General Practice Research Network (EGPRN) Meeting, held in Gothenburg (8–11 May 2025). The conference, focused on “Telehealth: Its Benefits, Quality and Safety”, brought together leading experts in primary care, digital health and telemedicine.
These are the goals of a project involving researchers from 5 different EU countries. This study has already produced evidence for the induction of a specific protein during COVID-19 disease. New information to guide predictive and personalized medicine may be obtained in the near future thanks to this discovery.
